Ablation of ventricular tachycardia in 2021

Nowadays, ablation of ventricular tachycardia (VT) in structural heart disease is an increasingly used procedure. In fact, it is the most effective strategy in controlling arrhythmic burden in VT patients. The ablative approaches are the result of the last 10 years of technological advances (Catheters, 3D mapping systems) and the constant study of the pathophysiological mechanisms underlying arrhythmic circuits. This presentation seeks to revisit the state of the art in the ablative treatment of VT.